Stay updated on Elotuzumab & Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page.

Latest updates to the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page
- Check5 days agoChange DetectedThe history now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history updated: added Revision: v3.3.2 and removed Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedDeleted notice about lapse in government funding and operating status, which does not affect the study record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check55 days agoChange DetectedNo substantive changes to core study content are evident between the old and new versions; the differences appear to be minor formatting or status-label updates only. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdates add a new date and a new study status entry, replacing an older date; core content appears unaffected.SummaryDifference0.9%

- Check84 days agoChange DetectedCore content updated with a government-operating-status notice and a version upgrade to v3.2.0, replacing the previous v3.1.0.SummaryDifference10%

Stay in the know with updates to Elotuzumab & Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elotuzumab & Lenalidomide Post-Transplant Clinical Trial page.